<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35027067</PMID><DateCompleted><Year>2022</Year><Month>01</Month><Day>20</Day></DateCompleted><DateRevised><Year>2022</Year><Month>12</Month><Day>07</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1741-7015</ISSN><JournalIssue CitedMedium="Internet"><Volume>20</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month><Day>14</Day></PubDate></JournalIssue><Title>BMC medicine</Title><ISOAbbreviation>BMC Med</ISOAbbreviation></Journal><ArticleTitle>Long-term perturbation of the peripheral immune system months after SARS-CoV-2 infection.</ArticleTitle><Pagination><StartPage>26</StartPage><MedlinePgn>26</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">26</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12916-021-02228-6</ELocationID><Abstract><AbstractText Label="BACKGROUND">Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly infectious respiratory virus which is responsible for the coronavirus disease 2019 (COVID-19) pandemic. It is increasingly clear that recovered individuals, even those who had mild COVID-19, can suffer from persistent symptoms for many months after infection, a condition referred to as "long COVID", post-acute sequelae of COVID-19 (PASC), post-acute COVID-19 syndrome, or post COVID-19 condition. However, despite the plethora of research on COVID-19, relatively little is known about the molecular underpinnings of these long-term effects.</AbstractText><AbstractText Label="METHODS">We have undertaken an integrated analysis of immune responses in blood at a transcriptional, cellular, and serological level at 12, 16, and 24&#x2009;weeks post-infection (wpi) in 69 patients recovering from mild, moderate, severe, or critical COVID-19 in comparison to healthy uninfected controls. Twenty-one of these patients were referred to a long COVID clinic and &gt;&#x2009;50% reported ongoing symptoms more than 6&#x2009;months post-infection.</AbstractText><AbstractText Label="RESULTS">Anti-Spike and anti-RBD IgG responses were largely stable up to 24 wpi and correlated with disease severity. Deep immunophenotyping revealed significant differences in multiple innate (NK cells, LD neutrophils, CXCR3+ monocytes) and adaptive immune populations (T helper, T follicular helper, and regulatory T cells) in convalescent individuals compared to healthy controls, which were most strongly evident at 12 and 16 wpi. RNA sequencing revealed significant perturbations to gene expression in COVID-19 convalescents until at least 6&#x2009;months post-infection. We also uncovered significant differences in the transcriptome at 24 wpi of convalescents who were referred to a long COVID clinic compared to those who were not.</AbstractText><AbstractText Label="CONCLUSIONS">Variation in the rate of recovery from infection at a cellular and transcriptional level may explain the persistence of symptoms associated with long COVID in some individuals.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Ryan</LastName><ForeName>Feargal J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5001, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hope</LastName><ForeName>Christopher M</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Women's and Children's Health Network, North Adelaide, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Immunology, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Masavuli</LastName><ForeName>Makutiro G</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lynn</LastName><ForeName>Miriam A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5001, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mekonnen</LastName><ForeName>Zelalem A</ForeName><Initials>ZA</Initials><AffiliationInfo><Affiliation>Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yeow</LastName><ForeName>Arthur Eng Lip</ForeName><Initials>AEL</Initials><AffiliationInfo><Affiliation>Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garcia-Valtanen</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Al-Delfi</LastName><ForeName>Zahraa</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gummow</LastName><ForeName>Jason</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Gene Silencing and Expression Core Facility, Adelaide Health and Medical Sciences, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferguson</LastName><ForeName>Catherine</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>O'Connor</LastName><ForeName>Stephanie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Royal Adelaide Hospital, Central Adelaide Local Health Network and Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Reddi</LastName><ForeName>Benjamin A J</ForeName><Initials>BAJ</Initials><AffiliationInfo><Affiliation>Intensive Care Unit, Royal Adelaide Hospital, Central Adelaide Local Health Network and Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hissaria</LastName><ForeName>Pravin</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shaw</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kok-Lim</LastName><ForeName>Chuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Infectious Diseases Department, Royal Adelaide Hospital, Central Adelaide Local Health Network, Adelaide, SA, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Microbiology and Infectious Diseases Department, SA Pathology, Adelaide, SA, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gleadle</LastName><ForeName>Jonathan M</ForeName><Initials>JM</Initials><AffiliationInfo><Affiliation>Department of Renal Medicine, Flinders Medical Centre, Flinders University, Bedford Park, SA, 5042, Australia.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, 5042, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beard</LastName><ForeName>Michael R</ForeName><Initials>MR</Initials><AffiliationInfo><Affiliation>Research Centre for Infectious Diseases, School of Biological Sciences, University of Adelaide, Adelaide, SA, 5005, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Barry</LastName><ForeName>Simon C</ForeName><Initials>SC</Initials><AffiliationInfo><Affiliation>Women's and Children's Health Network, North Adelaide, SA, Australia. simon.barry@adelaide.edu.au.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Molecular Immunology, Robinson Research Institute, University of Adelaide, Adelaide, SA, Australia. simon.barry@adelaide.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Grubor-Bauk</LastName><ForeName>Branka</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Viral Immunology Group, Adelaide Medical School, University of Adelaide and Basil Hetzel Institute for Translational Health Research, Adelaide, SA, Australia. branka.grubor@adelaide.edu.au.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Lynn</LastName><ForeName>David J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, SA, 5001, Australia. david.lynn@sahmri.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flinders Health and Medical Research Institute, Flinders University, Bedford Park, SA, 5042, Australia. david.lynn@sahmri.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>01</Month><Day>14</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Med</MedlineTA><NlmUniqueID>101190723</NlmUniqueID><ISSNLinking>1741-7015</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007107" MajorTopicYN="N">Immune System</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Antibody responses</Keyword><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">Convalescent patients</Keyword><Keyword MajorTopicYN="N">Immunity</Keyword><Keyword MajorTopicYN="N">Immunophenotyping</Keyword><Keyword MajorTopicYN="N">Infection</Keyword><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post COVID-19 condition</Keyword><Keyword MajorTopicYN="N">Post-acute sequelae of COVID-19 (PASC)</Keyword><Keyword MajorTopicYN="N">RNA-Seq</Keyword><Keyword MajorTopicYN="N">SARS-CoV-2</Keyword><Keyword MajorTopicYN="N">T cell</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>14</Day><Hour>5</Hour><Minute>31</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>1</Month><Day>21</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>1</Month><Day>14</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35027067</ArticleId><ArticleId IdType="pmc">PMC8758383</ArticleId><ArticleId IdType="doi">10.1186/s12916-021-02228-6</ArticleId><ArticleId IdType="pii">10.1186/s12916-021-02228-6</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Marshall M. COVID&#x2019;s toll on smell and taste: what scientists do and don&#x2019;t know. Nature. 2021;589(7842):342&#x2013;343. doi: 10.1038/d41586-021-00055-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/d41586-021-00055-6</ArticleId><ArticleId IdType="pubmed">33452511</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, Zhang L, Fan G, Xu J, Gu X, Cheng Z, Yu T, Xia J, Wei Y, Wu W, Xie X, Yin W, Li H, Liu M, Xiao Y, Gao H, Guo L, Xie J, Wang G, Jiang R, Gao Z, Jin Q, Wang J, Cao B. Clinical features of patients infected with 2019 novel coronavirus in Wuhan. China Lancet. 2020;395(10223):497&#x2013;506. doi: 10.1016/S0140-6736(20)30183-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30183-5</ArticleId><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong E, Du H, Gardner L. An interactive web-based dashboard to track COVID-19 in real time. Lancet Infect Dis. 2020;20(5):533&#x2013;534. doi: 10.1016/S1473-3099(20)30120-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30120-1</ArticleId><ArticleId IdType="pmc">PMC7159018</ArticleId><ArticleId IdType="pubmed">32087114</ArticleId></ArticleIdList></Reference><Reference><Citation>Carfi A, Bernabei R, Landi F, Gemelli Against C-P-ACSG. Persistent symptoms in patients after acute COVID-19. JAMA. 2020;324(6):603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, Kang L, Guo L, Liu M, Zhou X, Luo J, Huang Z, Tu S, Zhao Y, Chen L, Xu D, Li Y, Li C, Peng L, Li Y, Xie W, Cui D, Shang L, Fan G, Xu J, Wang G, Wang Y, Zhong J, Wang C, Wang J, Zhang D, Cao B. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397(10270):220&#x2013;232. doi: 10.1016/S0140-6736(20)32656-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo PE, Baricich A, Zeppegno P, Avanzi GC, Baldon G, Bartolomei G, Battaglia M, Battistini S, Binda V, Borg M, Cantaluppi V, Castello LM, Clivati E, Cisari C, Costanzo M, Croce A, Cuneo D, de Benedittis C, de Vecchi S, Feggi A, Gai M, Gambaro E, Gattoni E, Gramaglia C, Grisafi L, Guerriero C, Hayden E, Jona A, Invernizzi M, Lorenzini L, Loreti L, Martelli M, Marzullo P, Matino E, Panero A, Parachini E, Patrucco F, Patti G, Pirovano A, Prosperini P, Quaglino R, Rigamonti C, Sainaghi PP, Vecchi C, Zecca E, Pirisi M. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. 2021;4(1):e2036142. doi: 10.1001/jamanetworkopen.2020.36142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Taboada M, Carinena A, Moreno E, Rodriguez N, Dominguez MJ, Casal A, et al. Post-COVID-19 functional status six-months after hospitalization. J Infect. 2020;82(4):e31&#x2013;ee3. doi: 10.1016/j.jinf.2020.12.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2020.12.022</ArticleId><ArticleId IdType="pmc">PMC7834022</ArticleId><ArticleId IdType="pubmed">33373650</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Perez O, Merino E, Leon-Ramirez JM, Andres M, Ramos JM, Arenas-Jimenez J, et al. Post-acute COVID-19 Syndrome. Incidence and risk factors: a Mediterranean cohort study. J Infect. 2021;82(3):378&#x2013;383. doi: 10.1016/j.jinf.2021.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jinf.2021.01.004</ArticleId><ArticleId IdType="pmc">PMC7802523</ArticleId><ArticleId IdType="pubmed">33450302</ArticleId></ArticleIdList></Reference><Reference><Citation>Yelin D, Wirtheim E, Vetter P, Kalil AC, Bruchfeld J, Runold M, Guaraldi G, Mussini C, Gudiol C, Pujol M, Bandera A, Scudeller L, Paul M, Kaiser L, Leibovici L. Long-term consequences of COVID-19: research needs. Lancet Infect Dis. 2020;20(10):1115&#x2013;1117. doi: 10.1016/S1473-3099(20)30701-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(20)30701-5</ArticleId><ArticleId IdType="pmc">PMC7462626</ArticleId><ArticleId IdType="pubmed">32888409</ArticleId></ArticleIdList></Reference><Reference><Citation>Mandal S, Barnett J, Brill SE, Brown JS, Denneny EK, Hare SS, Heightman M, Hillman TE, Jacob J, Jarvis HC, Lipman MCI, Naidu SB, Nair A, Porter JC, Tomlinson GS, Hurst JR, ARC Study Group &#x2018;Long-COVID&#x2019;: a cross-sectional study of persisting symptoms, biomarker and imaging abnormalities following hospitalisation for COVID-19. Thorax. 2020;76(4):396&#x2013;398. doi: 10.1136/thoraxjnl-2020-215818.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-215818</ArticleId><ArticleId IdType="pmc">PMC7615158</ArticleId><ArticleId IdType="pubmed">33172844</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnold DT, Hamilton FW, Milne A, Morley AJ, Viner J, Attwood M, Noel A, Gunning S, Hatrick J, Hamilton S, Elvers KT, Hyams C, Bibby A, Moran E, Adamali HI, Dodd JW, Maskell NA, Barratt SL. Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax. 2020;76(4):399&#x2013;401. doi: 10.1136/thoraxjnl-2020-216086.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216086</ArticleId><ArticleId IdType="pmc">PMC7716340</ArticleId><ArticleId IdType="pubmed">33273026</ArticleId></ArticleIdList></Reference><Reference><Citation>Stavem K, Ghanima W, Olsen MK, Gilboe HM, Einvik G. Persistent symptoms 1.5-6&#x2009;months after COVID-19 in non-hospitalised subjects: a population-based cohort study. Thorax. 2020;76(4):405&#x2013;407. doi: 10.1136/thoraxjnl-2020-216377.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/thoraxjnl-2020-216377</ArticleId><ArticleId IdType="pmc">PMC7716295</ArticleId><ArticleId IdType="pubmed">33273028</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark DV, Kibuuka H, Millard M, Wakabi S, Lukwago L, Taylor A, Eller MA, Eller LA, Michael NL, Honko AN, Olinger GG, Jr, Schoepp RJ, Hepburn MJ, Hensley LE, Robb ML. Long-term sequelae after Ebola virus disease in Bundibugyo, Uganda: a retrospective cohort study. Lancet Infect Dis. 2015;15(8):905&#x2013;912. doi: 10.1016/S1473-3099(15)70152-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(15)70152-0</ArticleId><ArticleId IdType="pubmed">25910637</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngai JC, Ko FW, Ng SS, To KW, Tong M, Hui DS. The long-term impact of severe acute respiratory syndrome on pulmonary function, exercise capacity and health status. Respirology. 2010;15(3):543&#x2013;550. doi: 10.1111/j.1440-1843.2010.01720.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1843.2010.01720.x</ArticleId><ArticleId IdType="pmc">PMC7192220</ArticleId><ArticleId IdType="pubmed">20337995</ArticleId></ArticleIdList></Reference><Reference><Citation>Files JK, Boppana S, Perez MD, Sarkar S, Lowman KE, Qin K, Sterrett S, Carlin E, Bansal A, Sabbaj S, Long DM, Kutsch O, Kobie J, Goepfert PA, Erdmann N. Sustained cellular immune dysregulation in individuals recovering from SARS-CoV-2 infection. J Clin Invest. 2021;131(1):e140491. doi: 10.1172/JCI140491.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI140491</ArticleId><ArticleId IdType="pmc">PMC7773371</ArticleId><ArticleId IdType="pubmed">33119547</ArticleId></ArticleIdList></Reference><Reference><Citation>Chioh FW, Fong S-W, Young BE, Wu K-X, Siau A, Krishnan S, et al. Convalescent COVID-19 patients are susceptible to endothelial dysfunction due to persistent immune activation. Elife. 2021;10:e64909. doi: 10.7554/eLife.64909.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.64909</ArticleId><ArticleId IdType="pmc">PMC7987341</ArticleId><ArticleId IdType="pubmed">33752798</ArticleId></ArticleIdList></Reference><Reference><Citation>Wen W, Su W, Tang H, Le W, Zhang X, Zheng Y, et al. Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing. Cell Discov. 2020;6(1):31. doi: 10.1038/s41421-020-0168-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41421-020-0168-9</ArticleId><ArticleId IdType="pmc">PMC7197635</ArticleId><ArticleId IdType="pubmed">32377375</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X, Wen W, Fan X, Hou W, Su B, Cai P, Li J, Liu Y, Tang F, Zhang F, Yang Y, He J, Ma W, He J, Wang P, Cao Q, Chen F, Chen Y, Cheng X, Deng G, Deng X, Ding W, Feng Y, Gan R, Guo C, Guo W, He S, Jiang C, Liang J, Li YM, Lin J, Ling Y, Liu H, Liu J, Liu N, Liu SQ, Luo M, Ma Q, Song Q, Sun W, Wang GX, Wang F, Wang Y, Wen X, Wu Q, Xu G, Xie X, Xiong X, Xing X, Xu H, Yin C, Yu D, Yu K, Yuan J, Zhang B, Zhang P, Zhang T, Zhao J, Zhao P, Zhou J, Zhou W, Zhong S, Zhong X, Zhang S, Zhu L, Zhu P, Zou B, Zou J, Zuo Z, Bai F, Huang X, Zhou P, Jiang Q, Huang Z, Bei JX, Wei L, Bian XW, Liu X, Cheng T, Li X, Zhao P, Wang FS, Wang H, Su B, Zhang Z, Qu K, Wang X, Chen J, Jin R, Zhang Z. COVID-19 immune features revealed by a large-scale single-cell transcriptome atlas. Cell. 2021;184(23):1815&#x2013;1913. doi: 10.1016/j.cell.2021.10.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2021.10.023</ArticleId><ArticleId IdType="pmc">PMC8582084</ArticleId><ArticleId IdType="pubmed">34767776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng HY, Xu M, Yang CX, Tian RR, Zhang M, Li JJ, Wang XC, Ding ZL, Li GM, Li XL, He YQ, Dong XQ, Yao YG, Zheng YT. Longitudinal transcriptome analyses show robust T cell immunity during recovery from COVID-19. Sig Transduct Target Ther. 2020;5(1):294. doi: 10.1038/s41392-020-00457-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-020-00457-4</ArticleId><ArticleId IdType="pmc">PMC7758413</ArticleId><ArticleId IdType="pubmed">33361761</ArticleId></ArticleIdList></Reference><Reference><Citation>Bergamaschi L, Mescia F, Turner L, Hanson AL, Kotagiri P, Dunmore BJ, Ruffieux H, de Sa A, Huhn O, Morgan MD, Gerber PP, Wills MR, Baker S, Calero-Nieto FJ, Doffinger R, Dougan G, Elmer A, Goodfellow IG, Gupta RK, Hosmillo M, Hunter K, Kingston N, Lehner PJ, Matheson NJ, Nicholson JK, Petrunkina AM, Richardson S, Saunders C, Thaventhiran JED, Toonen EJM, Weekes MP, Cambridge Institute of Therapeutic Immunology and Infectious Disease-National Institute of Health Research (CITIID-NIHR) COVID BioResource Collaboration. G&#xf6;ttgens B, Toshner M, Hess C, Bradley JR, Lyons PA, Smith KGC. Longitudinal analysis reveals that delayed bystander CD8+ T cell activation and early immune pathology distinguish severe COVID-19 from mild disease. Immunity. 2021;54(6):1257&#x2013;1275. doi: 10.1016/j.immuni.2021.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.05.010</ArticleId><ArticleId IdType="pmc">PMC8125900</ArticleId><ArticleId IdType="pubmed">34051148</ArticleId></ArticleIdList></Reference><Reference><Citation>NIH. Clinical Spectrum of SARS-CoV-2 Infection 2021 [updated 17/12/2020]. Available from: https://www.covid19treatmentguidelines.nih.gov/overview/clinical-spectrum. Accessed 18 Dec 2020.</Citation></Reference><Reference><Citation>Corman VM, Landt O, Kaiser M, Molenkamp R, Meijer A, Chu DK, et al. Detection of 2019 novel coronavirus (2019-nCoV) by real-time RT-PCR. Eurosurveillance. 2020;25(3):2000045. doi: 10.2807/1560-7917.ES.2020.25.3.2000045.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES.2020.25.3.2000045</ArticleId><ArticleId IdType="pmc">PMC6988269</ArticleId><ArticleId IdType="pubmed">31992387</ArticleId></ArticleIdList></Reference><Reference><Citation>Hsieh C-L, Goldsmith JA, Schaub JM, DiVenere AM, Kuo H-C, Javanmardi K, et al. Structure-based design of prefusion-stabilized SARS-CoV-2 spikes. Science. 2020;369(6510):1501&#x2013;1505. doi: 10.1126/science.abd0826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abd0826</ArticleId><ArticleId IdType="pmc">PMC7402631</ArticleId><ArticleId IdType="pubmed">32703906</ArticleId></ArticleIdList></Reference><Reference><Citation>Amanat F, Stadlbauer D, Strohmeier S, Nguyen TH, Chromikova V, McMahon M, et al. A serological assay to detect SARS-CoV-2 seroconversion in humans. Nat Med. 2020;26(7):1033&#x2013;1036. doi: 10.1038/s41591-020-0913-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0913-5</ArticleId><ArticleId IdType="pmc">PMC8183627</ArticleId><ArticleId IdType="pubmed">32398876</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews S. FastQC: a quality control tool for high throughput sequence data; 2010. Available online at: http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.</Citation></Reference><Reference><Citation>Ewels P, Magnusson M, Lundin S, Kaller M. MultiQC: summarize analysis results for multiple tools and samples in a single report. Bioinformatics. 2016;32(19):3047&#x2013;3048. doi: 10.1093/bioinformatics/btw354.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw354</ArticleId><ArticleId IdType="pmc">PMC5039924</ArticleId><ArticleId IdType="pubmed">27312411</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30(15):2114&#x2013;2120. doi: 10.1093/bioinformatics/btu170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu170</ArticleId><ArticleId IdType="pmc">PMC4103590</ArticleId><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Langmead B, Salzberg SL. HISAT: a fast spliced aligner with low memory requirements. Nat Methods. 2015;12(4):357&#x2013;360. doi: 10.1038/nmeth.3317.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.3317</ArticleId><ArticleId IdType="pmc">PMC4655817</ArticleId><ArticleId IdType="pubmed">25751142</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30(7):923&#x2013;930. doi: 10.1093/bioinformatics/btt656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26(1):139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Leek JT. svaseq: removing batch effects and other unwanted noise from sequencing data. Nucleic Acids Res. 2014;42(21):e161. doi: 10.1093/nar/gku864.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gku864</ArticleId><ArticleId IdType="pmc">PMC4245966</ArticleId><ArticleId IdType="pubmed">25294822</ArticleId></ArticleIdList></Reference><Reference><Citation>Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, Schmidt DS, Johnson SE, Milton A, Rajam G, Kasturi S, Carlone GM, Quinn C, Chaussabel D, Palucka AK, Mulligan MJ, Ahmed R, Stephens DS, Nakaya HI, Pulendran B. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. 2014;15(2):195&#x2013;204. doi: 10.1038/ni.2789.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.2789</ArticleId><ArticleId IdType="pmc">PMC3946932</ArticleId><ArticleId IdType="pubmed">24336226</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-Seq data. BMC Bioinformatics. 2013;14(1):7. doi: 10.1186/1471-2105-14-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-14-7</ArticleId><ArticleId IdType="pmc">PMC3618321</ArticleId><ArticleId IdType="pubmed">23323831</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, Cook JR, Nordvig AS, Shalev D, Sehrawat TS, Ahluwalia N, Bikdeli B, Dietz D, der-Nigoghossian C, Liyanage-Don N, Rosner GF, Bernstein EJ, Mohan S, Beckley AA, Seres DS, Choueiri TK, Uriel N, Ausiello JC, Accili D, Freedberg DE, Baldwin M, Schwartz A, Brodie D, Garcia CK, Elkind MSV, Connors JM, Bilezikian JP, Landry DW, Wan EY. Post-acute COVID-19 syndrome. Nat Med. 2021;27(4):601&#x2013;615. doi: 10.1038/s41591-021-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Australia GoS. Government of South Australia; 2021 Available from: https://www.covid-19.sa.gov.au/home/dashboard. Accessed 15 Sept 2021.</Citation></Reference><Reference><Citation>Dan JM, Mateus J, Kato Y, Hastie KM, Yu ED, Faliti CE, et al. Immunological memory to SARS-CoV-2 assessed for up to 8&#x2009;months after infection. Science. 2021;371(6529):eabf4063. doi: 10.1126/science.abf4063.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abf4063</ArticleId><ArticleId IdType="pmc">PMC7919858</ArticleId><ArticleId IdType="pubmed">33408181</ArticleId></ArticleIdList></Reference><Reference><Citation>Piccoli L, Park Y-J, Tortorici MA, Czudnochowski N, Walls AC, Beltramello M, et al. Mapping neutralizing and immunodominant sites on the SARS-CoV-2 spike receptor-binding domain by structure-guided high-resolution serology. Cell. 2020;183(4):1024&#x2013;42. e21. doi: 10.1016/j.cell.2020.09.037.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.037</ArticleId><ArticleId IdType="pmc">PMC7494283</ArticleId><ArticleId IdType="pubmed">32991844</ArticleId></ArticleIdList></Reference><Reference><Citation>Robbiani DF, Gaebler C, Muecksch F, Lorenzi JC, Wang Z, Cho A, et al. Convergent antibody responses to SARS-CoV-2 in convalescent individuals. Nature. 2020;584(7821):437&#x2013;442. doi: 10.1038/s41586-020-2456-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2456-9</ArticleId><ArticleId IdType="pmc">PMC7442695</ArticleId><ArticleId IdType="pubmed">32555388</ArticleId></ArticleIdList></Reference><Reference><Citation>Metzemaekers M, Gouwy M, Proost P. Neutrophil chemoattractant receptors in health and disease: double-edged swords. Cell Mol Immunol. 2020;17(5):433&#x2013;450. doi: 10.1038/s41423-020-0412-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-0412-0</ArticleId><ArticleId IdType="pmc">PMC7192912</ArticleId><ArticleId IdType="pubmed">32238918</ArticleId></ArticleIdList></Reference><Reference><Citation>Klingler J, Weiss S, Itri V, Liu X, Oguntuyo KY, Stevens C, et al. Role of IgM and IgA Antibodies in the Neutralization of SARS-CoV-2. medRxiv. 2020. 10.1101/2020.08.18.20177303.</Citation></Reference><Reference><Citation>Duhen T, Duhen R, Lanzavecchia A, Sallusto F, Campbell DJ. Functionally distinct subsets of human FOXP3+ Treg cells that phenotypically mirror effector Th cells. Blood. 2012;119(19):4430&#x2013;4440. doi: 10.1182/blood-2011-11-392324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2011-11-392324</ArticleId><ArticleId IdType="pmc">PMC3362361</ArticleId><ArticleId IdType="pubmed">22438251</ArticleId></ArticleIdList></Reference><Reference><Citation>Hope CM, Welch J, Mohandas A, Pederson S, Hill D, Gundsambuu B, Eastaff-Leung N, Grosse R, Bresatz S, Ang G, Papademetrios M, Zola H, Duhen T, Campbell D, Brown CY, Krumbiegel D, Sadlon T, Couper JJ, Barry SC. Peptidase inhibitor 16 identifies a human regulatory T-cell subset with reduced FOXP3 expression over the first year of recent onset type 1 diabetes. Eur J Immunol. 2019;49(8):1235&#x2013;1250. doi: 10.1002/eji.201948094.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/eji.201948094</ArticleId><ArticleId IdType="pubmed">31127857</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaplan MH. Th9 cells: differentiation and disease. Immunol Rev. 2013;252(1):104&#x2013;115. doi: 10.1111/imr.12028.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imr.12028</ArticleId><ArticleId IdType="pmc">PMC3982928</ArticleId><ArticleId IdType="pubmed">23405898</ArticleId></ArticleIdList></Reference><Reference><Citation>Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H, Durham SR, Schmidt-Weber CB, Cavani A. Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest. 2009;119(12):3573&#x2013;3585. doi: 10.1172/JCI40202.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI40202</ArticleId><ArticleId IdType="pmc">PMC2786807</ArticleId><ArticleId IdType="pubmed">19920355</ArticleId></ArticleIdList></Reference><Reference><Citation>Mohr I, Sonenberg N. Host translation at the nexus of infection and immunity. Cell Host Microbe. 2012;12(4):470&#x2013;483. doi: 10.1016/j.chom.2012.09.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2012.09.006</ArticleId><ArticleId IdType="pmc">PMC7104986</ArticleId><ArticleId IdType="pubmed">23084916</ArticleId></ArticleIdList></Reference><Reference><Citation>Stern-Ginossar N, Thompson SR, Mathews MB, Mohr I. Translational control in virus-infected cells. Cold Spring Harbor Perspect Biol. 2019;11(3):a033001. doi: 10.1101/cshperspect.a033001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a033001</ArticleId><ArticleId IdType="pmc">PMC6396331</ArticleId><ArticleId IdType="pubmed">29891561</ArticleId></ArticleIdList></Reference><Reference><Citation>Schubert K, Karousis ED, Jomaa A, Scaiola A, Echeverria B, Gurzeler LA, Leibundgut M, Thiel V, M&#xfc;hlemann O, Ban N. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation. Nat Struct Mol Biol. 2020;27(10):959&#x2013;966. doi: 10.1038/s41594-020-0511-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41594-020-0511-8</ArticleId><ArticleId IdType="pubmed">32908316</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Lokugamage KG, Rozovics JM, Narayanan K, Semler BL, Makino S. SARS coronavirus nsp1 protein induces template-dependent endonucleolytic cleavage of mRNAs: viral mRNAs are resistant to nsp1-induced RNA cleavage. PLoS Pathogens. 2011;7(12):e1002433. doi: 10.1371/journal.ppat.1002433.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002433</ArticleId><ArticleId IdType="pmc">PMC3234236</ArticleId><ArticleId IdType="pubmed">22174690</ArticleId></ArticleIdList></Reference><Reference><Citation>Bianco C, Mohr I. Ribosome biogenesis restricts innate immune responses to virus infection and DNA. Elife. 2019;8:e49551. doi: 10.7554/eLife.49551.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.49551</ArticleId><ArticleId IdType="pmc">PMC6934380</ArticleId><ArticleId IdType="pubmed">31841110</ArticleId></ArticleIdList></Reference><Reference><Citation>Rampotas A, Pavord S. Platelet aggregates, a marker of severe COVID-19 disease. J Clin Pathol. 2020;74(11):750&#x2013;751. doi: 10.1136/jclinpath-2020-206933.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jclinpath-2020-206933</ArticleId><ArticleId IdType="pubmed">33067181</ArticleId></ArticleIdList></Reference><Reference><Citation>Reinecke F, Smeitink JA, Van Der Westhuizen FH. OXPHOS gene expression and control in mitochondrial disorders. Biochimica et Biophysica Acta (BBA)-Mol Basis Dis. 2009;1792(12):1113&#x2013;1121. doi: 10.1016/j.bbadis.2009.04.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2009.04.003</ArticleId><ArticleId IdType="pubmed">19389473</ArticleId></ArticleIdList></Reference><Reference><Citation>Apaijai N, Sriwichaiin S, Phrommintikul A, Jaiwongkam T, Kerdphoo S, Chansirikarnjana S, Thongmung N, Mahantassanapong U, Vathesatogkit P, Kitiyakara C, Sritara P, Chattipakorn N, Chattipakorn SC. Cognitive impairment is associated with mitochondrial dysfunction in peripheral blood mononuclear cells of elderly population. Sci Rep. 2020;10(1):21400. doi: 10.1038/s41598-020-78551-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-78551-4</ArticleId><ArticleId IdType="pmc">PMC7723050</ArticleId><ArticleId IdType="pubmed">33293556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharyya S, Vrati S. The Malat1 long non-coding RNA is upregulated by signalling through the PERK axis of unfolded protein response during flavivirus infection. Sci Rep. 2015;5(1):17794. doi: 10.1038/srep17794.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep17794</ArticleId><ArticleId IdType="pmc">PMC4669524</ArticleId><ArticleId IdType="pubmed">26634309</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang K, Wang C, Vagts C, Raguveer V, Finn PW, Perkins DL. LncRNAs NEAT1 and MALAT1 Differentiate Inflammation in Severe COVID-19 Patients. medRxiv. 2021. 10.1101/2021.03.26.21254445.</Citation></Reference><Reference><Citation>Hewitson JP, West KA, James KR, Rani GF, Dey N, Romano A, et al. Malat1 suppresses immunity to infection through promoting expression of Maf and IL-10 in Th cells. J Immunol. 2020;204(11):2949&#x2013;2960. doi: 10.4049/jimmunol.1900940.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1900940</ArticleId><ArticleId IdType="pmc">PMC7231852</ArticleId><ArticleId IdType="pubmed">32321759</ArticleId></ArticleIdList></Reference><Reference><Citation>Gutschner T, H&#xe4;mmerle M, Eissmann M, Hsu J, Kim Y, Hung G, et al. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013;73(3):1180&#x2013;1189. doi: 10.1158/0008-5472.CAN-12-2850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-12-2850</ArticleId><ArticleId IdType="pmc">PMC3589741</ArticleId><ArticleId IdType="pubmed">23243023</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhattacharjee S, Banerjee M. Immune thrombocytopenia secondary to COVID-19: a systematic review. SN Compr Clin Med. 2020;2(11):2048&#x2013;2058. doi: 10.1007/s42399-020-00521-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s42399-020-00521-8</ArticleId><ArticleId IdType="pmc">PMC7501509</ArticleId><ArticleId IdType="pubmed">32984764</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen W, Yang B, Li Z, Wang P, Chen Y, Zhou H. Sudden severe thrombocytopenia in a patient in the recovery stage of COVID-19. Lancet Haematol. 2020;7(8):e624. doi: 10.1016/S2352-3026(20)30175-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30175-7</ArticleId><ArticleId IdType="pmc">PMC7247794</ArticleId><ArticleId IdType="pubmed">32464105</ArticleId></ArticleIdList></Reference><Reference><Citation>Bomhof G, Mutsaers PGNJ, Leebeek FWG, te Boekhorst PAW, Hofland J, Croles FN, Jansen AJG. COVID-19-associated immune thrombocytopenia. Br J Haematol. 2020;190(2):e61&#x2013;ee4. doi: 10.1111/bjh.16850.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bjh.16850</ArticleId><ArticleId IdType="pmc">PMC7276755</ArticleId><ArticleId IdType="pubmed">32420612</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang M, Ng MH, Li CK. Thrombocytopenia in patients with severe acute respiratory syndrome (review) Hematology (Amsterdam, Netherlands) 2005;10(2):101&#x2013;105.</Citation><ArticleIdList><ArticleId IdType="pubmed">16019455</ArticleId></ArticleIdList></Reference><Reference><Citation>Joob B, Wiwanitkit V. Thrombocytopenia: an important presentation of new emerging H7N9 influenza. Platelets. 2014;25(4):308. doi: 10.3109/09537104.2013.815342.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/09537104.2013.815342</ArticleId><ArticleId IdType="pubmed">23909680</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp TM, Mu&#xf1;oz-Jord&#xe1;n J, Perez-Padilla J, Bello-Pag&#xe1;n MI, Rivera A, Pastula DM, et al. Zika virus infection associated with severe thrombocytopenia. Clin Infect Dis. 2016;63(9):1198&#x2013;1201.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5176332</ArticleId><ArticleId IdType="pubmed">27418575</ArticleId></ArticleIdList></Reference><Reference><Citation>Korfias S, Stranjalis G, Papadimitriou A, Psachoulia C, Daskalakis G, Antsaklis A, Sakas D. Serum S-100B protein as a biochemical marker of brain injury: a review of current concepts. Curr Med Chem. 2006;13(30):3719&#x2013;3731. doi: 10.2174/092986706779026129.</Citation><ArticleIdList><ArticleId IdType="doi">10.2174/092986706779026129</ArticleId><ArticleId IdType="pubmed">17168733</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequalae of COVID-19. Nature. 2021;594(7862):259&#x2013;264. doi: 10.1038/s41586-021-03553-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Koutsakos M, Rowntree LC, Hensen L, Chua BY, van de Sandt CE, Habel JR, Zhang W, Jia X, Kedzierski L, Ashhurst TM, Putri GH, Marsh-Wakefield F, Read MN, Edwards DN, Clemens EB, Wong CY, Mordant FL, Juno JA, Amanat F, Audsley J, Holmes NE, Gordon CL, Smibert OC, Trubiano JA, Hughes CM, Catton M, Denholm JT, Tong SYC, Doolan DL, Kotsimbos TC, Jackson DC, Krammer F, Godfrey DI, Chung AW, King NJC, Lewin SR, Wheatley AK, Kent SJ, Subbarao K, McMahon J, Thevarajan I, Nguyen THO, Cheng AC, Kedzierska K. Integrated immune dynamics define correlates of COVID-19 severity and antibody responses. Cell Rep Med. 2021;2(3):100208. doi: 10.1016/j.xcrm.2021.100208.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100208</ArticleId><ArticleId IdType="pmc">PMC7862905</ArticleId><ArticleId IdType="pubmed">33564749</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Yang X, Wang H, Li Z, Deng H, Liu J, et al. Analysis of the long-term impact on cellular immunity in COVID-19-recovered individuals reveals a profound NKT cell impairment. mBio. 2021;12(2):e00085&#x2013;e00021.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8092197</ArticleId><ArticleId IdType="pubmed">33906918</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, Lee MJ, Wei B, Parks B, Pi R, Martinez-Colon GJ, et al. Multi-omic profiling reveals widespread dysregulation of innate immunity and hematopoiesis in COVID-19. J Exp Med. 2021;218(8):e20210582. doi: 10.1084/jem.20210582.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20210582</ArticleId><ArticleId IdType="pmc">PMC8210586</ArticleId><ArticleId IdType="pubmed">34128959</ArticleId></ArticleIdList></Reference><Reference><Citation>Kratzer B, Trapin D, Ettel P, Kormoczi U, Rottal A, Tuppy F, et al. Immunological imprint of COVID-19 on human peripheral blood leukocyte populations. Allergy. 2021;76(3):751&#x2013;765. doi: 10.1111/all.14647.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/all.14647</ArticleId><ArticleId IdType="pmc">PMC7984452</ArticleId><ArticleId IdType="pubmed">33128792</ArticleId></ArticleIdList></Reference><Reference><Citation>Peluso MJ, Deitchman AN, Torres L, Iyer NS, Munter SE, Nixon CC, Donatelli J, Thanh C, Takahashi S, Hakim J, Turcios K, Janson O, Hoh R, Tai V, Hernandez Y, Fehrman EA, Spinelli MA, Gandhi M, Trinh L, Wrin T, Petropoulos CJ, Aweeka FT, Rodriguez-Barraquer I, Kelly JD, Martin JN, Deeks SG, Greenhouse B, Rutishauser RL, Henrich TJ. Long-term SARS-CoV-2-specific immune and inflammatory responses in individuals recovering from COVID-19 with and without post-acute symptoms. Cell Rep. 2021;36(6):109518. doi: 10.1016/j.celrep.2021.109518.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109518</ArticleId><ArticleId IdType="pmc">PMC8342976</ArticleId><ArticleId IdType="pubmed">34358460</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheon IS, Li C, Son YM, Goplen NP, Wu Y, Cassmann T, et al. Immune signatures underlying post-acute COVID-19 lung sequelae. Sci Immunol. 2021;6(65):eabk1741. doi: 10.1126/sciimmunol.abk1741.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abk1741</ArticleId><ArticleId IdType="pmc">PMC8763087</ArticleId><ArticleId IdType="pubmed">34591653</ArticleId></ArticleIdList></Reference><Reference><Citation>Pradenas E, Trinite B, Urrea V, Marfil S, Avila-Nieto C, de la Concepcion ML R, et al. Stable neutralizing antibody levels 6&#x2009;months after mild and severe COVID-19 episodes. Med (N Y) 2021;2(3):313&#x2013;320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7847406</ArticleId><ArticleId IdType="pubmed">33554155</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J, Liang B, Chen C, Wang H, Fang Y, Shen S, et al. SARS-CoV-2 infection induces sustained humoral immune responses in convalescent patients following symptomatic COVID-19. Nat Commun. 2021;12(1):1813. doi: 10.1038/s41467-021-22034-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-22034-1</ArticleId><ArticleId IdType="pmc">PMC7985370</ArticleId><ArticleId IdType="pubmed">33753738</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonifacius A, Tischer-Zimmermann S, Dragon AC, Gussarow D, Vogel A, Krettek U, G&#xf6;decke N, Yilmaz M, Kraft ARM, Hoeper MM, Pink I, Schmidt JJ, Li Y, Welte T, Maecker-Kolhoff B, Martens J, Berger MM, Lobenwein C, Stankov MV, Cornberg M, David S, Behrens GMN, Witzke O, Blasczyk R, Eiz-Vesper B. COVID-19 immune signatures reveal stable antiviral T cell function despite declining humoral responses. Immunity. 2021;54(2):340&#x2013;354. doi: 10.1016/j.immuni.2021.01.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2021.01.008</ArticleId><ArticleId IdType="pmc">PMC7871825</ArticleId><ArticleId IdType="pubmed">33567252</ArticleId></ArticleIdList></Reference><Reference><Citation>Wheatley AK, Juno JA, Wang JJ, Selva KJ, Reynaldi A, Tan HX, Lee WS, Wragg KM, Kelly HG, Esterbauer R, Davis SK, Kent HE, Mordant FL, Schlub TE, Gordon DL, Khoury DS, Subbarao K, Cromer D, Gordon TP, Chung AW, Davenport MP, Kent SJ. Evolution of immune responses to SARS-CoV-2 in mild-moderate COVID-19. Nat Commun. 2021;12(1):1162. doi: 10.1038/s41467-021-21444-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-21444-5</ArticleId><ArticleId IdType="pmc">PMC7896046</ArticleId><ArticleId IdType="pubmed">33608522</ArticleId></ArticleIdList></Reference><Reference><Citation>Bilich T, Nelde A, Heitmann JS, Maringer Y, Roerden M, Bauer J, et al. T cell and antibody kinetics delineate SARS-CoV-2 peptides mediating long-term immune responses in COVID-19 convalescent individuals. Sci Transl Med. 2021;13(590):eabf7517. doi: 10.1126/scitranslmed.abf7517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.abf7517</ArticleId><ArticleId IdType="pmc">PMC8128286</ArticleId><ArticleId IdType="pubmed">33723016</ArticleId></ArticleIdList></Reference><Reference><Citation>Harrington WE, Trakhimets O, Andrade DV, Dambrauskas N, Raappana A, Jiang Y, Houck J, Selman W, Yang A, Vigdorovich V, Yeung W, Haglund M, Wallner J, Oldroyd A, Hardy S, Stewart SWA, Gervassi A, van Voorhis W, Frenkel L, Sather DN. Rapid decline of neutralizing antibodies is associated with decay of IgM in adults recovered from mild COVID-19. Cell Rep Med. 2021;2(4):100253. doi: 10.1016/j.xcrm.2021.100253.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100253</ArticleId><ArticleId IdType="pmc">PMC8020863</ArticleId><ArticleId IdType="pubmed">33842901</ArticleId></ArticleIdList></Reference><Reference><Citation>Gasser R, Cloutier M, Prevost J, Fink C, Ducas E, Ding S, et al. Major role of IgM in the neutralizing activity of convalescent plasma against SARS-CoV-2. Cell Rep. 2021;34(9):108790. doi: 10.1016/j.celrep.2021.108790.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.108790</ArticleId><ArticleId IdType="pmc">PMC7874916</ArticleId><ArticleId IdType="pubmed">33596407</ArticleId></ArticleIdList></Reference><Reference><Citation>Yates JL, Ehrbar DJ, Hunt DT, Girardin RC, Dupuis AP, 2nd, Payne AF, et al. Serological analysis reveals an imbalanced IgG subclass composition associated with COVID-19 disease severity. Cell Rep Med. 2021;15(7):100329. doi: 10.1016/j.xcrm.2021.100329.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100329</ArticleId><ArticleId IdType="pmc">PMC8205277</ArticleId><ArticleId IdType="pubmed">34151306</ArticleId></ArticleIdList></Reference><Reference><Citation>Haslwanter D, Dieterle ME, Wec AZ, O&#x2019;Brien CM, Sakharkar M, Florez C, et al. A combination of RBD and NTD neutralizing antibodies limits the generation of SARS-CoV-2 spike neutralization-escape mutants. bioRxiv. 2021. 10.1128/mBio.02473-21.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8546647</ArticleId><ArticleId IdType="pubmed">34607456</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Zhao J, Nguyen LNT, Adkins JL, Schank M, Khanal S, Nguyen LN, Dang X, Cao D, Thakuri BKC, Lu Z, Zhang J, Zhang Y, Wu XY, el Gazzar M, Ning S, Moorman JP, Yao ZQ. Blockade of SARS-CoV-2 spike protein-mediated cell-cell fusion using COVID-19 convalescent plasma. Sci Rep. 2021;11(1):5558. doi: 10.1038/s41598-021-84840-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-84840-3</ArticleId><ArticleId IdType="pmc">PMC7946952</ArticleId><ArticleId IdType="pubmed">33692386</ArticleId></ArticleIdList></Reference><Reference><Citation>Stephenson E, Reynolds G, Botting RA, Calero-Nieto FJ, Morgan MD, Tuong ZK, et al. Single-cell multi-omics analysis of the immune response in COVID-19. Nat Med. 2021;27(5):904&#x2013;916. doi: 10.1038/s41591-021-01329-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01329-2</ArticleId><ArticleId IdType="pmc">PMC8121667</ArticleId><ArticleId IdType="pubmed">33879890</ArticleId></ArticleIdList></Reference><Reference><Citation>Pusnik J, Richter E, Schulte B, Dolscheid-Pommerich R, Bode C, Putensen C, et al. Memory B cells targeting SARS-CoV-2 spike protein and their dependence on CD4(+) T cell help. Cell Rep. 2021;35(13):109320. doi: 10.1016/j.celrep.2021.109320.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2021.109320</ArticleId><ArticleId IdType="pmc">PMC8192958</ArticleId><ArticleId IdType="pubmed">34146478</ArticleId></ArticleIdList></Reference><Reference><Citation>Galv&#xe1;n-Pe&#xf1;a S, Leon J, Chowdhary K, Michelson DA, Vijaykumar B, Yang L, Magnuson AM, Chen F, Manickas-Hill Z, Piechocka-Trocha A, Worrall DP, Hall KE, Ghebremichael M, Walker BD, Li JZ, Yu XG, MGH COVID-19 Collection &amp; Processing Team. Mathis D, Benoist C. Profound Treg perturbations correlate with COVID-19 severity. Proc Natl Acad Sci. 2021;118(37):e2111315118. doi: 10.1073/pnas.2111315118.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.2111315118</ArticleId><ArticleId IdType="pmc">PMC8449354</ArticleId><ArticleId IdType="pubmed">34433692</ArticleId></ArticleIdList></Reference><Reference><Citation>Boothby IC, Cohen JN, Rosenblum MD. Regulatory T cells in skin injury: at the crossroads of tolerance and tissue repair. Sci Immunol. 2020;5(47):eaaz9631. doi: 10.1126/sciimmunol.aaz9631.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aaz9631</ArticleId><ArticleId IdType="pmc">PMC7274208</ArticleId><ArticleId IdType="pubmed">32358172</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil VS, Madrigal A, Schmiedel BJ, Clarke J, O&#x2019;Rourke P, de Silva AD, et al. Precursors of human CD4(+) cytotoxic T lymphocytes identified by single-cell transcriptome analysis. Sci Immunol. 2018;3(19):eaan8664. doi: 10.1126/sciimmunol.aan8664.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.aan8664</ArticleId><ArticleId IdType="pmc">PMC5931334</ArticleId><ArticleId IdType="pubmed">29352091</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian Y, Babor M, Lane J, Schulten V, Patil VS, Seumois G, Rosales SL, Fu Z, Picarda G, Burel J, Zapardiel-Gonzalo J, Tennekoon RN, de Silva AD, Premawansa S, Premawansa G, Wijewickrama A, Greenbaum JA, Vijayanand P, Weiskopf D, Sette A, Peters B. Unique phenotypes and clonal expansions of human CD4 effector memory T cells re-expressing CD45RA. Nat Commun. 2017;8(1):1473. doi: 10.1038/s41467-017-01728-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01728-5</ArticleId><ArticleId IdType="pmc">PMC5684192</ArticleId><ArticleId IdType="pubmed">29133794</ArticleId></ArticleIdList></Reference><Reference><Citation>Linterman MA, Pierson W, Lee SK, Kallies A, Kawamoto S, Rayner TF, Srivastava M, Divekar DP, Beaton L, Hogan JJ, Fagarasan S, Liston A, Smith KGC, Vinuesa CG. Foxp3+ follicular regulatory T cells control the germinal center response. Nat Med. 2011;17(8):975&#x2013;982. doi: 10.1038/nm.2425.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.2425</ArticleId><ArticleId IdType="pmc">PMC3182542</ArticleId><ArticleId IdType="pubmed">21785433</ArticleId></ArticleIdList></Reference><Reference><Citation>Lund JM, Hsing L, Pham TT, Rudensky AY. Coordination of early protective immunity to viral infection by regulatory T cells. Science. 2008;320(5880):1220&#x2013;1224. doi: 10.1126/science.1155209.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1155209</ArticleId><ArticleId IdType="pmc">PMC2519146</ArticleId><ArticleId IdType="pubmed">18436744</ArticleId></ArticleIdList></Reference><Reference><Citation>Juno JA, Tan HX, Lee WS, Reynaldi A, Kelly HG, Wragg K, Esterbauer R, Kent HE, Batten CJ, Mordant FL, Gherardin NA, Pymm P, Dietrich MH, Scott NE, Tham WH, Godfrey DI, Subbarao K, Davenport MP, Kent SJ, Wheatley AK. Humoral and circulating follicular helper T cell responses in recovered patients with COVID-19. Nat Med. 2020;26(9):1428&#x2013;1434. doi: 10.1038/s41591-020-0995-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0995-0</ArticleId><ArticleId IdType="pubmed">32661393</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaneko N, Kuo HH, Boucau J, Farmer JR, Allard-Chamard H, Mahajan VS, et al. Loss of Bcl-6-expressing T follicular helper cells and germinal centers in COVID-19. Cell. 2020;183(1):143&#x2013;57.e13. doi: 10.1016/j.cell.2020.08.025.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.025</ArticleId><ArticleId IdType="pmc">PMC7437499</ArticleId><ArticleId IdType="pubmed">32877699</ArticleId></ArticleIdList></Reference><Reference><Citation>Overmyer KA, Shishkova E, Miller IJ, Balnis J, Bernstein MN, Peters-Clarke TM, Meyer JG, Quan Q, Muehlbauer LK, Trujillo EA, He Y, Chopra A, Chieng HC, Tiwari A, Judson MA, Paulson B, Brademan DR, Zhu Y, Serrano LR, Linke V, Drake LA, Adam AP, Schwartz BS, Singer HA, Swanson S, Mosher DF, Stewart R, Coon JJ, Jaitovich A. Large-scale multi-omic analysis of COVID-19 severity. Cell Syst. 2021;12(1):23&#x2013;40. doi: 10.1016/j.cels.2020.10.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cels.2020.10.003</ArticleId><ArticleId IdType="pmc">PMC7543711</ArticleId><ArticleId IdType="pubmed">33096026</ArticleId></ArticleIdList></Reference><Reference><Citation>Aschenbrenner AC, Mouktaroudi M, Kramer B, Oestreich M, Antonakos N, Nuesch-Germano M, et al. Disease severity-specific neutrophil signatures in blood transcriptomes stratify COVID-19 patients. Genome Med. 2021;13(1):7. doi: 10.1186/s13073-020-00823-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-020-00823-5</ArticleId><ArticleId IdType="pmc">PMC7805430</ArticleId><ArticleId IdType="pubmed">33441124</ArticleId></ArticleIdList></Reference><Reference><Citation>Manne BK, Denorme F, Middleton EA, Portier I, Rowley JW, Stubben C, Petrey AC, Tolley ND, Guo L, Cody M, Weyrich AS, Yost CC, Rondina MT, Campbell RA. Platelet gene expression and function in patients with COVID-19. Blood. 2020;136(11):1317&#x2013;1329. doi: 10.1182/blood.2020007214.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007214</ArticleId><ArticleId IdType="pmc">PMC7483430</ArticleId><ArticleId IdType="pubmed">32573711</ArticleId></ArticleIdList></Reference><Reference><Citation>Koupenova M, Corkrey HA, Vitseva O, Tanriverdi K, Somasundaran M, Liu P, Soofi S, Bhandari R, Godwin M, Parsi KM, Cousineau A, Maehr R, Wang JP, Cameron SJ, Rade J, Finberg RW, Freedman JE. SARS-CoV-2 initiates programmed cell death in platelets. Circ Res. 2021;129(6):631&#x2013;646. doi: 10.1161/CIRCRESAHA.121.319117.</Citation><ArticleIdList><ArticleId IdType="doi">10.1161/CIRCRESAHA.121.319117</ArticleId><ArticleId IdType="pmc">PMC8409903</ArticleId><ArticleId IdType="pubmed">34293929</ArticleId></ArticleIdList></Reference><Reference><Citation>Cameron B, Galbraith S, Zhang Y, Davenport T, Vollmer-Conna U, Wakefield D, Hickie I, Dunsmuir W, Whistler T, Vernon S, Reeves WC, Lloyd AR, Dubbo Infection Outcomes Study Gene expression correlates of postinfective fatigue syndrome after infectious mononucleosis. J Infect Dis. 2007;196(1):56&#x2013;66. doi: 10.1086/518614.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/518614</ArticleId><ArticleId IdType="pubmed">17538884</ArticleId></ArticleIdList></Reference><Reference><Citation>Saichi M, Ladjemi MZ, Korniotis S, Rousseau C, Ait Hamou Z, Massenet-Regad L, Amblard E, Noel F, Marie Y, Bouteiller D, Medvedovic J, P&#xe8;ne F, Soumelis V. Single-cell RNA sequencing of blood antigen-presenting cells in severe COVID-19 reveals multi-process defects in antiviral immunity. Nat Cell Biol. 2021;23(5):538&#x2013;551. doi: 10.1038/s41556-021-00681-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41556-021-00681-2</ArticleId><ArticleId IdType="pubmed">33972731</ArticleId></ArticleIdList></Reference><Reference><Citation>Tarke A, Sidney J, Kidd CK, Dan JM, Ramirez SI, Yu ED, Mateus J, da Silva Antunes R, Moore E, Rubiro P, Methot N, Phillips E, Mallal S, Frazier A, Rawlings SA, Greenbaum JA, Peters B, Smith DM, Crotty S, Weiskopf D, Grifoni A, Sette A. Comprehensive analysis of T cell immunodominance and immunoprevalence of SARS-CoV-2 epitopes in COVID-19 cases. Cell Rep Med. 2021;2(2):100204. doi: 10.1016/j.xcrm.2021.100204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.xcrm.2021.100204</ArticleId><ArticleId IdType="pmc">PMC7837622</ArticleId><ArticleId IdType="pubmed">33521695</ArticleId></ArticleIdList></Reference><Reference><Citation>Sekine T, Perez-Potti A, Rivera-Ballesteros O, Stralin K, Gorin JB, Olsson A, et al. Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19. Cell. 2020;183(1):158&#x2013;168. doi: 10.1016/j.cell.2020.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.08.017</ArticleId><ArticleId IdType="pmc">PMC7427556</ArticleId><ArticleId IdType="pubmed">32979941</ArticleId></ArticleIdList></Reference><Reference><Citation>Gene Expression Omnibus https://identifiers.org/geo/GSE169687. (2021).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>